A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main purpose of the study is to evaluate the safety, reactogenicity, and the humoral immunogenicity of mRNA-1010 and comparator influenza vaccines against homologous influenza A and B strains at Day 29.
Epistemonikos ID: b1ff1d6603184f90eb99ac37663a2fdfe9387da0
First added on: May 14, 2024